Emerging technologies for diagnosing Alzheimer's disease :
نام عام مواد
[Book]
ساير اطلاعات عنواني
innovating with care /
نام نخستين پديدآور
Marianne Boenink, Harro van Lente, Ellen Moors, editors
مشخصات ظاهری
نام خاص و کميت اثر
1 online resource.
فروست
عنوان فروست
Health, technology and society
یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references and index
یادداشتهای مربوط به مندرجات
متن يادداشت
Series Editors' Introduction; Acknowledgements; Contents; Notes on Contributors; List of Abbreviations; List of Figures ; List of Tables ; 1: Emerging Technologies for Diagnosing Alzheimer's Disease: Innovating with€Care; The Desirability of€Biomarker Diagnostics of€Alzheimer's Disease; Responsible Innovation; Innovating with€Care; Chapter Outline; References; Part I: Biomedical Research on€Alzheimer's Disease Diagnostics: Background and€Trends; 2: The Diagnosis and€Treatment of€Alzheimer's: Are We€Being (Ir)responsible?; History of€Diagnosis and Treatment
متن يادداشت
4: Biomarkers for€Alzheimer's Disease: Searching for€the€Missing Link Between Biology and€Clinic Biomarkers: Connecting Biology and€Clinic; AD Biomarker Research: Development and€Clinical Drivers; AD Biomarker Research in€Practice: The€LeARN Project; Choosing Candidate Markers and€Technological Platforms; Choosing Outcome Measures; Choices Related to€Patient Inclusion and€Follow-Up; Conclusion; References; 5: Care and€Responsibility in€Building Futures for€Alzheimer's Disease Research; Cohort Studies; The Sociality of€Cohorts; The MRC Cognitive Function and€Ageing Study
متن يادداشت
Current State of€the€Alzheimer's Field Crafting an€Innovative But Responsible Future; Early or Timely Diagnosis; Finding the€Cure or Even an€Effective Therapy; A Case Study of€'Irresponsibility'; Towards a€More Responsible Future; New Approaches; References; 3: On Short Cuts: The€Complexity of€Studying the€Early Diagnosis and€Prevention of€Alzheimer's Disease; Two Decades, One Question; Around 1993; Around 2013; Even Milder Than Mild Cognitive Impairment: Prevention and€Prediction; Simplifications and€Short Cuts: On€Studying Early Dementia; References
متن يادداشت
Distribution by Patients' Preferences Revisiting Current Practices of€AD-Diagnostics: From€Good to€Better?; Value-Laden Taxonomies and€Taxonomy-Laden Preferences; Improving Practices of€AD-Diagnostics; To Conclude: Emergent Biomarker Tools for€AD; References; 7: Understanding Cognitive Screening Tools: Navigating Uncertainty in€Everyday Clinical Practice; Methods; Clinician-Patient Interaction: Making of€Provisionality; National Dementia CQUIN and€Early Diagnosis: Constraining 'Care Work'; Discussion; References
متن يادداشت
Mediating the€Cognitive Function and€Ageing Study Meeting the€Cohort; Care and€Responsibility; References; Part II: Diagnosing Alzheimer's Disease: Current Practices; 6: Grey Matters: Emergent Biomarkers and€Good Alzheimer's Diagnostics; Background and€Methods; Current Practices of€AD-Diagnostics in€the€Netherlands: A€Heterogeneous Field; Good AD-Diagnostics: Differences; The Good Diagnosis: Five Diagnostic Values; Modes of€Diagnosing: 'Pulling Out All the€Stops' or 'Holding Back'; Distributing Differences; Distribution by Taxonomic Considerations
بدون عنوان
0
بدون عنوان
8
بدون عنوان
8
بدون عنوان
8
بدون عنوان
8
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
This book explores international biomedical research and development on the early diagnosis of Alzheimer's disease. It offers timely, multidisciplinary reflections on the social and ethical issues raised by promises of early diagnostics and asks under which conditions emerging diagnostic technologies can be considered a responsible innovation. The initial chapters in this edited volume provide an overview and a critical discussion of recent developments in biomedical research on Alzheimer's disease. Subsequent contributions explore the values at stake in current practices of dealing with Alzheimer's disease and dementia, both within and outside the biomedical domain. Novel diagnostic technologies for Alzheimer's disease emerge in a complex and shifting field, full of controversies. Innovating with care requires a precise mapping of how concepts, values and responsibilities are filled in through the confrontation of practices. In doing so, the volume offers a practice-based approach of responsible innovation that is also applicable to other fields of innovation